NYSE : NUVB
Nuvation Bio Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 4.77 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.67B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Nuvation Bio Inc. (NUVB) reported revenue of 169.90M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 169.90M | 62.90M | 7.87M | |||
| Cost of Revenue | 20.09M | 9.30M | 7.08M | |||
| Gross Profit | 149.81M | 53.60M | 795.00K | |||
| Selling, General & Admin | 158.59M | 151.56M | 69.23M | 28.53M | 31.92M | 24.28M |
| Research & Development | 128.85M | 115.11M | 99.12M | 71.29M | 87.81M | 65.25M |
| Operating Expenses | 287.44M | 266.67M | 168.35M | 99.82M | 119.73M | 89.53M |
| Operating Income | -137.63M | -213.06M | -167.56M | -99.82M | -119.73M | -89.53M |
| Interest Expense | -26.67M | -13.68M | -341.00K | |||
| Interest & Investment Income | 21.03M | 21.43M | 27.06M | 24.61M | 7.45M | 2.96M |
| Other Non Operating Income (Expenses) | 2.89M | 717.00K | -2.02M | -452.00K | 9.31M | 3.59M |
| EBT Excluding Unusual Items | -140.38M | -204.60M | -142.86M | -75.66M | -102.97M | -82.98M |
| Gain (Loss) on Sale of Investments | 20.00K | 5.00K | -12.00K | -139.00K | -1.23M | -80.00K |
| Gain (Loss) on Sale of Assets | 2.00K | -33.00K | ||||
| Pretax Income | -149.83M | -204.63M | -567.94M | -75.80M | -104.20M | -86.85M |
| Net Income | -149.83M | -204.63M | -567.94M | -75.80M | -104.20M | -86.85M |
| Net Income to Common | -149.83M | -204.63M | -567.94M | -75.80M | -104.20M | -86.85M |
| Shares Outstanding (Basic) | 341.54M | 341.54M | 268.77M | 218.88M | 216.72M | 197.89M |
| Shares Outstanding (Diluted) | 341.54M | 341.54M | 268.77M | 218.88M | 216.72M | 197.89M |
| EPS (Basic) | -0.44 | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 |
| EPS (Diluted) | -0.44 | -0.60 | -2.11 | -0.35 | -0.48 | -0.44 |
| Free Cash Flow | -120.92M | -173.78M | -130.57M | -68.07M | -96.48M | -68.47M |
| Free Cash Flow Per Share | -0.35 | -0.51 | -0.49 | -0.31 | -0.45 | -0.35 |
| Gross Margin | 88.17% | 85.22% | 10.10% | |||
| Operating Margin | -81.00% | -338.72% | -2,128.25% | |||
| Profit Margin | -88.19% | -325.31% | -7,213.76% | |||
| Free Cash Flow Margin | -71.17% | -276.27% | -1,658.52% | |||
| EBITDA | -135.48M | -211.32M | -166.87M | -99.60M | -119.53M | -89.35M |
| D&A For EBITDA | 2.15M | 1.74M | 683.00K | 222.00K | 199.00K | 184.00K |
| EBIT | -137.63M | -213.06M | -167.56M | -99.82M | -119.73M | -89.53M |
| Revenue as Reported | 169.90M | 62.90M | 7.87M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 258.60M | 164.09M | 35.72M | 42.65M | 101.10M | 132.42M |
| Short-Term Investments | 402.35M | 365.12M | 466.97M | 568.56M | 559.91M | 632.97M |
| Cash & Short-Term Investments | 660.96M | 529.21M | 502.69M | 611.21M | 661.01M | 765.39M |
| Accounts Receivable | 27.83M | 16.08M | 12.72M | |||
| Other Receivables | 3.89M | 3.29M | 3.57M | 3.70M | 2.48M | 3.04M |
| Receivables | 31.71M | 19.36M | 16.29M | 3.70M | 2.48M | 3.04M |
| Inventory | 19.90M | 11.41M | ||||
| Prepaid Expenses | 13.86M | 11.54M | 7.27M | 1.52M | 3.82M | 3.64M |
| Total Current Assets | 726.43M | 571.52M | 526.25M | 616.43M | 667.32M | 772.07M |
| Property, Plant & Equipment | 3.96M | 4.48M | 2.99M | 4.32M | 4.68M | 3.66M |
| Other Intangible Assets | 10.29M | 11.21M | 4.62M | |||
| Other Long-Term Assets | 3.82M | 7.61M | 6.76M | 728.00K | 138.00K | 421.00K |
| Total Assets | 744.50M | 594.82M | 540.63M | 621.48M | 672.14M | 776.15M |
| Accounts Payable | 12.09M | 9.48M | 6.35M | 2.21M | 2.14M | 3.92M |
| Accrued Expenses | 45.20M | 44.90M | 32.15M | 9.65M | 9.70M | 11.73M |
| Short-Term Debt | 5.89M | 5.72M | 6.28M | |||
| Current Portion of Long-Term Debt | 13.00M | 9.59M | ||||
| Current Portion of Leases | 1.72M | 1.88M | 1.66M | 1.97M | 1.21M | 863.00K |
| Current Income Taxes Payable | 286.00K | 679.00K | 144.00K | 112.00K | 402.00K | |
| Current Unearned Revenue | 8.86M | 7.51M | 11.12M | |||
| Other Current Liabilities | 2.87M | |||||
| Total Current Liabilities | 86.75M | 82.23M | 58.24M | 13.97M | 13.16M | 16.93M |
| Long-Term Debt | 393.75M | 47.21M | ||||
| Long-Term Leases | 1.91M | 2.54M | 969.00K | 2.04M | 3.05M | 2.19M |
| Long-Term Unearned Revenue | 8.23M | 11.30M | 15.57M | |||
| Other Long-Term Liabilities | 145.82M | 2.05M | 353.00K | 850.00K | 11.04M | |
| Total Liabilities | 490.64M | 289.11M | 76.84M | 16.36M | 17.07M | 30.15M |
| Common Stock | 1.43B | 1.42B | 1.37B | 947.75M | 927.60M | 909.99M |
| Retained Earnings | -1.17B | -1.12B | -910.74M | -342.80M | -267.00M | -162.80M |
| Comprehensive Income & Other | -2.61M | -187.00K | 573.00K | 181.00K | -5.53M | -1.19M |
| Total Common Equity | 253.86M | 305.72M | 463.79M | 605.12M | 655.08M | 746.00M |
| Shareholders' Equity | 253.86M | 305.72M | 463.79M | 605.12M | 655.08M | 746.00M |
| Total Liabilities & Equity | 744.50M | 594.82M | 540.63M | 621.48M | 672.14M | 776.15M |
| Total Debt | 416.26M | 66.94M | 8.91M | 4.01M | 4.26M | 3.06M |
| Net Cash (Debt) | 244.69M | 462.27M | 493.78M | 607.21M | 656.75M | 762.34M |
| Net Cash Per Share | 0.72 | 1.35 | 1.84 | 2.77 | 3.03 | 3.85 |
| Filing Date Shares Outstanding | 351.12M | 347.60M | 338.68M | 219.05M | 218.80M | 219.06M |
| Total Common Shares Outstanding | 349.82M | 346.50M | 337.84M | 219.05M | 218.63M | 217.95M |
| Working Capital | 639.68M | 489.29M | 468.01M | 602.46M | 654.16M | 755.15M |
| Book Value Per Share | 0.73 | 0.88 | 1.37 | 2.76 | 3.00 | 3.42 |
| Tangible Book Value | 243.57M | 294.50M | 459.17M | 605.12M | 655.08M | 746.00M |
| Tangible Book Value Per Share | 0.70 | 0.85 | 1.36 | 2.76 | 3.00 | 3.42 |
| Machinery | 1.18M | 1.11M | 1.04M | 1.04M | 833.00K | |
| Construction In Progress | 28.00K | |||||
| Leasehold Improvements | 536.00K | 353.00K | 342.00K | 316.00K | 244.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -149.83M | -204.63M | -567.94M | -75.80M | -104.20M | -86.85M |
| Depreciation & Amortization | 2.15M | 1.74M | 683.00K | 222.00K | 199.00K | 184.00K |
| Other Amortization | 1.31M | 662.00K | ||||
| Loss (Gain) From Sale of Assets | -2.00K | 33.00K | 229.00K | 10.00K | 50.00K | |
| Asset Writedown & Restructuring Costs | 425.07M | 3.79M | ||||
| Loss (Gain) From Sale of Investments | -4.04M | -5.29M | -8.99M | -11.92M | 4.90M | 4.67M |
| Stock-Based Compensation | 35.50M | 35.89M | 32.27M | 19.51M | 16.29M | 9.27M |
| Other Operating Activities | 25.88M | 10.14M | 764.00K | -564.00K | -9.90M | -4.05M |
| Change in Accounts Receivable | -25.13M | -3.35M | -12.72M | |||
| Change in Inventory | -19.35M | -11.41M | ||||
| Change in Accounts Payable | -9.83M | 3.13M | -1.65M | 70.00K | -1.79M | 1.86M |
| Change in Unearned Revenue | -5.10M | -7.87M | 3.94M | |||
| Change in Other Net Operating Assets | 27.92M | 7.52M | -2.07M | 470.00K | -1.66M | 2.93M |
| Operating Cash Flow | -120.52M | -173.43M | -130.41M | -68.00M | -96.11M | -68.19M |
| Capital Expenditures | -403.00K | -354.00K | -162.00K | -69.00K | -370.00K | -282.00K |
| Sale of Property, Plant & Equipment | 14.00K | 13.00K | ||||
| Cash Acquisitions | 12.43M | |||||
| Sale (Purchase) of Intangibles | -8.00M | -8.00M | ||||
| Investment in Securities | -38.78M | 107.87M | 110.44M | 8.98M | 63.81M | -454.39M |
| Investing Cash Flow | -47.18M | 99.52M | 122.70M | 8.92M | 63.46M | -454.67M |
| Long-Term Debt Issued | 210.10M | 12.61M | ||||
| Total Debt Issued | 254.95M | 210.10M | 12.61M | |||
| Long-Term Debt Repaid | -12.39M | -17.16M | ||||
| Total Debt Repaid | -72.26M | -12.39M | -17.16M | |||
| Net Debt Issued (Repaid) | 182.69M | 197.71M | -4.55M | |||
| Issuance of Common Stock | 14.70M | 11.42M | 4.88M | 628.00K | 1.33M | 758.00K |
| Other Financing Activities | -18.25M | -6.60M | 624.77M | |||
| Financing Cash Flow | 179.14M | 202.53M | 331.00K | 628.00K | 1.33M | 625.53M |
| Foreign Exchange Rate Adjustments | -798.00K | -265.00K | 453.00K | |||
| Net Cash Flow | 10.63M | 128.36M | -6.93M | -58.45M | -31.32M | 102.67M |
| Free Cash Flow | -120.92M | -173.78M | -130.57M | -68.07M | -96.48M | -68.47M |
| Free Cash Flow Margin | -71.17% | -276.27% | -1,658.52% | |||
| Free Cash Flow Per Share | -0.35 | -0.51 | -0.49 | -0.31 | -0.45 | -0.35 |
| Levered Free Cash Flow | -112.11M | -115.78M | -52.19M | -41.59M | -62.44M | -39.03M |
| Unlevered Free Cash Flow | -96.76M | -107.89M | -51.97M | -41.59M | -62.44M | -39.03M |
| Change in Working Capital | -31.49M | -11.98M | -12.51M | 540.00K | -3.45M | 4.79M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.67B | 3.07B | 895.27M | 330.61M | 419.31M | 1.85B |
| Enterprise Value | 1.43B | 2.73B | 357.32M | -284.27M | -250.16M | 1.06B |
| Last Close Price | 4.76 | 8.96 | 2.66 | 1.51 | 1.92 | 8.50 |
| PS Ratio | 9.84 | 48.83 | 113.71 | |||
| PB Ratio | 6.56 | 10.05 | 1.93 | 0.55 | 0.64 | 2.48 |
| P/TBV Ratio | 6.86 | 10.43 | 1.95 | 0.55 | 0.64 | 2.48 |
| EV/Sales Ratio | 8.40 | 43.41 | 45.39 | |||
| Debt / Equity Ratio | 1.64 | 0.22 | 0.02 | 0.01 | 0.01 | 0.00 |
| Net Debt / Equity Ratio | -0.96 | -1.51 | -1.06 | -1.00 | -1.00 | -1.02 |
| Net Debt / EBITDA Ratio | 1.81 | 2.19 | 2.96 | 6.10 | 5.49 | 8.53 |
| Net Debt / FCF Ratio | 2.02 | 2.66 | 3.78 | 8.92 | 6.81 | 11.13 |
| Asset Turnover | 0.24 | 0.11 | 0.01 | |||
| Quick Ratio | 7.98 | 6.67 | 8.91 | 44.00 | 50.41 | 45.40 |
| Current Ratio | 8.37 | 6.95 | 9.04 | 44.11 | 50.70 | 45.62 |
| Return on Equity (ROE) | -47.81% | -53.18% | -106.27% | -12.03% | -14.87% | -18.07% |
| Return on Assets (ROA) | -12.36% | -23.46% | -18.02% | -9.64% | -10.33% | -11.21% |
| Return on Capital Employed (ROCE) | -20.90% | -41.60% | -34.70% | -16.40% | -18.20% | -11.80% |
| Earnings Yield | -9.22% | -6.66% | -63.44% | -22.93% | -24.85% | -4.69% |
| FCF Yield | -7.24% | -5.66% | -14.59% | -20.59% | -23.01% | -3.70% |
| Buyback Yield / Dilution | -4.49% | -27.07% | -22.79% | -1.00% | -9.52% | -102.90% |